Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Prostate Cancer

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    June 2019
  1. MOMOZAWA Y, Iwasaki Y, Hirata M, Liu X, et al
    Germline pathogenic variants in 7,636 Japanese patients with prostate cancer and 12,366 controls.
    J Natl Cancer Inst. 2019 Jun 19. pii: 5520440. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. JEON J, Olkhov-Mitsel E, Xie H, Yao CQ, et al
    Temporal stability and prognostic biomarker potential of the prostate cancer urine transcriptome.
    J Natl Cancer Inst. 2019 Jun 4. pii: 5510559. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2019
  3. HUSBY A, Wohlfahrt J, Melbye M
    Vasectomy and prostate cancer risk: a 38-year nationwide cohort study.
    J Natl Cancer Inst. 2019 May 23. pii: 5497506. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. MUCCI LA, Wilson KM, Preston MA, Giovannucci EL, et al
    Is vasectomy a cause of prostate cancer?
    J Natl Cancer Inst. 2019 May 23. pii: 5497503. doi: 10.1093.
    PubMed     Text format    


  5. KERNS SL, Fachal L, Dorling L, Barnett GC, et al
    Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.
    J Natl Cancer Inst. 2019 May 16. pii: 5490201. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2019
  6. DONDOSSOLA E, Casarin S, Paindelli C, De-Juan-Pardo EM, et al
    Radium 223-mediated zonal cytotoxicity of prostate cancer in bone.
    J Natl Cancer Inst. 2019 Jan 18. pii: 5292474. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2018
  7. WALSH PC
    RE: Risk of Prostate Cancer in Men Treated With 5alpha-Reductase Inhibitors-A Large Population-Based Prospective Study.
    J Natl Cancer Inst. 2018 Oct 30. pii: 5149366. doi: 10.1093.
    PubMed     Text format    


  8. ZHAO SG, Lehrer J, Chang SL, Das R, et al
    The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.
    J Natl Cancer Inst. 2018 Oct 13. pii: 5129111. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. MADAN RA, Gulley JL
    Finding an Immunologic Beachhead in the Prostate Cancer Microenvironment.
    J Natl Cancer Inst. 2018 Oct 13. pii: 5129110. doi: 10.1093.
    PubMed     Text format    


  10. YOO YA, Vatapalli R, Lysy B, Mok H, et al
    The Role of Castration-Resistant Bmi1+Sox2+ Cells in Driving Recurrence in Prostate Cancer.
    J Natl Cancer Inst. 2018 Oct 11. pii: 5127127. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. KARTHAUS WR, Sawyers CL
    Strategies to Identify and Target Cells of Origin in Prostate Cancer.
    J Natl Cancer Inst. 2018 Oct 11. pii: 5127123. doi: 10.1093.
    PubMed     Text format    


    September 2018
  12. MEIER KE
    Omega-3 Fatty Acids and Prostate Cancer: G Protein-Coupled Receptors to the Rescue.
    J Natl Cancer Inst. 2018 Sep 6. pii: 5091908. doi: 10.1093.
    PubMed     Text format    


  13. LIANG P, Henning SM, Guan J, Grogan T, et al
    Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer.
    J Natl Cancer Inst. 2018 Sep 6. pii: 5091911. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  14. YARMOLINSKY J, Bonilla C, Haycock PC, Langdon RJQ, et al
    Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis.
    J Natl Cancer Inst. 2018 May 17. pii: 4996958. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  15. VERMA V, Simone CB 2nd, Mishra MV
    Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    March 2018
  16. WALLERSTEDT A, Strom P, Gronberg H, Nordstrom T, et al
    Risk of Prostate Cancer in Men Treated With 5alpha-Reductase Inhibitors-A Large Population-Based Prospective Study.
    J Natl Cancer Inst. 2018 Mar 14. pii: 4935092. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. THOMPSON I JR., Goodman P, Tangen C
    Reduced Risk of Prostate Cancer With 5alpha-Reductase Inhibitors.
    J Natl Cancer Inst. 2018 Mar 14. pii: 4935098. doi: 10.1093.
    PubMed     Text format    


  18. UNGER JM, Hershman DL, Till C, Tangen CM, et al
    Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial.
    J Natl Cancer Inst. 2018 Mar 9. pii: 4925555. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  19. JOHNSON SB, Park HS, Gross CP, Yu JB, et al
    Use of Alternative Medicine for Cancer and Its Impact on Survival.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    December 2017
  20. WYATT AW, Annala M, Aggarwal R, Beja K, et al
    Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    October 2017
  21. BROUGHMAN JR, Basak R, Nielsen ME, Reeve BB, et al
    Prostate Cancer Patient Characteristics Associated With a Strong Preference to Preserve Sexual Function and Receipt of Active Surveillance.
    J Natl Cancer Inst. 2017 Oct 16. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2017
  22. CONTI DV, Wang K, Sheng X, Bensen JT, et al
    Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    April 2017
  23. BRIOLLAIS L, Ozcelik H, Xu J, Kwiatkowski M, et al
    Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    March 2017
  24. KELLY SP, Graubard BI, Andreotti G, Younes N, et al
    Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.
    J Natl Cancer Inst. 2017;109:1-9.
    PubMed     Text format     Abstract available


    February 2017
  25. POLLACK A, Kwon D, Walker G, Khor LY, et al
    Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer.
    J Natl Cancer Inst. 2017;109:1-8.
    PubMed     Text format     Abstract available


    January 2017
  26. GAO X, Li LY, Rassler J, Pang J, et al
    Prospective Study of CRMP4 Promoter Methylation in Prostate Biopsies as a Predictor For Lymph Node Metastases.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: